Go Pro
NYSE:CCM

Concord Medical Services Q4 2025 Earnings Report

Concord Medical Services logo
$3.58 +0.02 (+0.51%)
Closing price 09/25/2026 03:59 PM Eastern
Extended Trading
$3.60 +0.02 (+0.61%)
As of 09/25/2026 05:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Concord Medical Services EPS Results

Actual EPS
-$1.08
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Concord Medical Services Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Concord Medical Services Announcement Details

Quarter
Q4 2025
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Concord Medical Services Earnings Headlines

My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up Amazon and Netflix under $3 per share in 2005. Now the chief investment strategist at The Oxford Club has identified three AI stocks he believes could be the most profitable investments of the next decade.tc pixel
CCM Share News Today
Concord Medical Services Holdings Ltd
See More Concord Medical Services Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Concord Medical Services? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Concord Medical Services and other key companies, straight to your email.

About Concord Medical Services

Concord Medical Services (NYSE:CCM) is a healthcare services company focused on oncology care in China. The company has historically developed and operated a network of cancer treatment centers and provided specialized medical services through hospitals and outpatient facilities.

Its activities have included radiotherapy, diagnostic imaging, and other cancer-related services. Concord Medical has also provided hospital management, consulting, and equipment-related services, supporting healthcare institutions with the development and operation of oncology departments and treatment facilities.

Founded in 2004 and headquartered in Beijing, Concord Medical expanded its operations across major cities in China. The company completed an initial public offering on the New York Stock Exchange in 2009. Its American depositary shares subsequently ceased trading on the exchange following a later transition to private ownership.

View Concord Medical Services Profile